Lankenau Heart Group and Main Line HealthCare Primary Care earn national recognition for efforts to improve cardiovascular health for patients
The American Heart Association presents multiple awards for implementation of quality care for patients.
Lankenau Heart Group and Main Line HealthCare primary care physician practices, all part of Main Line Health, have been recognized by the American Heart Association (AHA) for their commitment to managing heart disease and stroke risk by controlling risk factors like high cholesterol, diabetes, and blood pressure. The three awards are a testament to the entire clinical team’s commitment to the prevention, diagnosis, treatment and management of cardiovascular disease.
Nearly half of all adults in the U.S. have experienced some form of cardiovascular disease – including heart attack, stroke and heart failure. Leading risk factors for cardiovascular disease include high cholesterol, type 2 diabetes, and uncontrolled high blood pressure, but through proper risk factor diagnosis and treatment, heart disease and stroke can be prevented or managed.
“These well-deserved awards recognize Lankenau Heart Group and Main Line HealthCare primary care physician practices for their ongoing commitment to keeping our patients well by not only following proven guidelines that reduce the onset or recurrence of cardiovascular disease, but also by providing education and guidance to help inform healthy decisions. These awards are a testament to the high quality and excellent care being provided across our practices” said William Gray, MD, System Chief of Cardiovascular Disease at Main Line Health.”
To improve quality of care and help people learn to manage their risk factors around high cholesterol, type 2 diabetes and/or blood pressure management, Lankenau Heat Group participates in the following programs and received achievement awards once again this year:
- Check. Change. Control. Cholesterol™ Participant
- Target: Type 2 Diabetes℠ Gold
- Target: BP™ Gold recognition from both the American Heart Association and the American Medical Association (AMA)
“Both Lankenau Heart Group and Main Line HealthCare are honored to be recognized by the American Heart Association. We appreciate being acknowledged for our dedication to helping our patients have the resources to manage risk factors and hopefully reduce or avoid heart attacks, stroke and other preventable heart concerns,” said Eric Mankin, MD, President, Main Line HealthCare. “Programs like the ones that address the real-world problems of high blood pressure, high cholesterol and uncontrolled type 2 diabetes are necessary to improve health today and avoid larger problems for many patients tomorrow.”
About Lankenau Heart Institute
Lankenau Heart Institute is Main Line Health’s premier comprehensive cardiovascular program, bringing together cardiologists, cardiovascular surgeons and advanced practice providers across the System’s four acute care hospitals: Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital. Through a coordinated approach, the Institute offers a full continuum of high-quality cardiovascular care — from prevention and diagnostics to clinical trials, advanced treatments and rehabilitation — with a commitment to excellence in outcomes and patient experience.
A nationally recognized leader in innovation and exceptional clinical outcomes, Lankenau Heart Institute is at the forefront of minimally invasive and transcatheter procedures for coronary revascularization, valve repair and replacement, complex aortic surgery and the treatment of advanced heart failure and arrhythmias. Its pioneering work in robotic-assisted and beating-heart techniques and minimally invasive and robotic valve repair continues to shape the future of cardiovascular care. With a robust and influential presence in national clinical trials, its physicians regularly participate in groundbreaking research focused on new therapies, technologies and procedures, primarily through less invasive approaches.
About Main Line Health
Main Line Health® is a not-for-profit health system serving the greater Philadelphia region. The System comprises five hospitals, seven health centers, more than 160 outpatient and physician practice locations, over 14,500 employees and more than 2,200 employed and independent physicians and advanced practice providers.
Founded in 1985, Main Line Health includes four of the region’s most respected acute care hospitals — Lankenau Medical Center, Bryn Mawr Hospital, Paoli Hospital and Riddle Hospital — as well as Bryn Mawr Rehab Hospital, one of the nation’s premier facilities for rehabilitative medicine. The System also includes Mirmont Treatment Center, which provides treatment and support for substance use disorders; Main Line Health HomeCare & Hospice; Main Line HealthCare, its employed multispecialty physician network; Lankenau Institute for Medical Research, a leading biomedical research organization; and Main Line Health Centers offering primary and specialty care, lab, radiology and other outpatient services in Broomall, Collegeville, Concordville, Devon, Exton, King of Prussia and Newtown Square.
Main Line Health brings together physicians, advanced practice providers, nurses, researchers and other healthcare professionals across a broad network of inpatient, outpatient, home-based and community-based services. Through this integrated approach, the System delivers high-quality, comprehensive care across the continuum — from primary care and preventive services to complex specialty, surgical, trauma, emergency, rehabilitative, behavioral health, home care and hospice services — with a focus on making care accessible in the communities where people live and work.
Main Line Health also collaborates with leading clinical partners to expand access to specialized care. Through its affiliation with Children's Hospital of Philadelphia, pediatric care is provided at select Main Line Health locations, including neonatal intensive care units at its acute care hospitals and Bryn Mawr Hospital’s Inpatient Pediatric Unit and Emergency Department. Jefferson Health neurosurgeons and neurointerventionalists also provide 24/7 specialized care, including neurointervention and lifesaving stroke care.
About Target: BP™
Target: BP is a national collaboration between the AHA and the AMA aimed at reducing the number of Americans who suffer from heart attacks and strokes each year by urging physician practices, health systems and patients to prioritize BP control. The initiative aims to help health care organizations improve blood pressure control rates through use of AMA MAP BP™ evidence-based protocol, and recognizes organizations committed to improving blood pressure control.
About Check. Change. Control. Cholesterol™
The American Heart Association, the world's leading voluntary organization dedicated to building longer, healthier lives, created the Check. Change. Control. Cholesterol™ initiative with national support from Amgen to improve awareness, detection and management of high cholesterol for consumers, patients and health care professionals.
About Target: Type 2 Diabetes™
The American Heart Association, the world’s leading voluntary organization dedicated to building longer, healthier lives, created the Target: Type 2 Diabetes™ initiative as a part of the Know Diabetes by Heart™ effort to raise awareness and understanding of the link between diabetes and cardiovascular disease among patients, caregivers and health care professionals as well as empower patients and care givers to better manage risk factors.
The Target: Type 2 Diabetes program supports physicians and care teams by offering access to the latest research, tools and resources to provide the latest cardiovascular and type 2 diabetes management and treatment guidelines.
Contact
Phil Ellingsworth, Jr.Director, Communications
Office: 484.580.1182
EllingsworthPh@mlhs.org